Japan’s Eisai seeks marketing nod for Alzheimer’s drug in South Korea
HQ Team June 8, 2023: Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority.
Drugs
Health
Medical
Sleeping pill can delay or stop onset of Alzheimer’s; study
Suvorexant, a commonly prescribed sleeping pill to help treat insomnia reduced levels of the Alzheimer’s-associated amyloid beta protein in the brain in a.
Drugs
Pharma
Eiasi files market authorization for Alzheimer’s drug in Japan
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Health
Medical
Pharma
Your age may say a lot about your cognitive health
A new artificial intelligence-driven model can analyse magnetic resonance imaging of brain scans to accurately capture cognitive decline linked to neurodegenerative diseases such.
Drugs
Pharma
FDA gives accelerated approval for Alzheimer’s drug
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.